Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History CDXS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics CDXS

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Codexis Inc

CDXS
Current price
2.88 USD +0.02 USD (+0.70%)
Last closed 2.81 USD
ISIN US1920051067
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 236 936 112 USD
Yield for 12 month -12.73 %
1Y
3Y
5Y
10Y
15Y
CDXS
21.11.2021 - 28.11.2021

Codexis, Inc. provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California. Address: 200 Penobscot Drive, Redwood City, CA, United States, 94063

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

7.08 USD

P/E Ratio

Dividend Yield

Financials CDXS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures CDXS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+59 345 000 USD

Last Year

+70 143 000 USD

Current Quarter

+7 543 000 USD

Last Quarter

+21 460 000 USD

Current Year

+43 057 000 USD

Last Year

+57 334 000 USD

Current Quarter

+4 811 000 USD

Last Quarter

+17 806 000 USD
EBITDA -62 063 000 USD
Operating Margin TTM -271.59 %
Price to Earnings
Return On Assets TTM -30.06 %
PEG Ratio -1.16
Return On Equity TTM -115.53 %
Wall Street Target Price 7.08 USD
Revenue TTM 49 815 000 USD
Book Value 0.60 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -55.80 %
Dividend Yield
Gross Profit TTM -12 309 000 USD
Earnings per share -0.98 USD
Diluted Eps TTM -0.98 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -149.47 %

Stock Valuation CDXS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 138.89
Enterprise Value Revenue 5.10
Price Sales TTM 4.76
Enterprise Value EBITDA -10.67
Price Book MRQ 5.12

Technical Indicators CDXS

For 52 Weeks

1.90 USD 6.08 USD
50 Day MA 2.47 USD
Shares Short Prior Month 6 355 406
200 Day MA 3.41 USD
Short Ratio 6.34
Shares Short 7 097 953
Short Percent 7.81 %